K. Magnus

发表

EPIDEMIOLOGIC EVALUATION OF CHEMOPROPHYLAXIS AGAINST TUBERCULOSIS: TWELVE YEARS FOLLOW-UP OF A COMMUNITY-WIDE CONTROLLED TRIAL WITH SPECIAL REFERENCE TO THE SAMPLING METHOD

O. Horwitz, K. Magnus, 1974 .

Epidemiological basis of tuberculosis eradication. 3. Risk of pulmonary tuberculosis after human and bovine infection.

K. Magnus, 1966, Bulletin of the World Health Organization.

Suppurative Lymphadenitis following Intradermal B.C.G. Vaccination of the Newborn

P. Q. Edwards, J. Guld, K. Magnus, 1955, British medical journal.

The effect of repeated tuberculin testing on post-vaccination allergy; a preliminary note.

K. Magnus, L. B. Edwards, 1955, Lancet.

The Effect of Universal Carbon‐Arc light Therapy on the Development of Immunity

P. Q. Edwards, I. Scheibel, K. Magnus, 1952, Acta paediatrica.

INTERAÇÕES MEDICAMENTOSAS ASSOCIADAS A FITOTERÁPICOS FORNECIDOS PELO SISTEMA ÚNICO DE SAÚDE Drug Interactions Associated with Herbal Provided by the Unified Health System

K. Magnus, L. Santos, Rafaela Dutra Felten, 2015 .

Diluents for stabilization of tuberculin.

H. Waaler, M. Magnusson, J. Guld, 1958, Bulletin of the World Health Organization.

Effect of intradermal tuberculin tests on BCG-induced allergy.

K. Magnus, 1957, Bulletin of the World Health Organization.

The significance of bovine tuberculous infection for human tuberculosis of today.

K. Magnus, 1968, Bulletin of the International Union against Tuberculosis.

Adsorption of tuberculin to glass.

H. Waaler, M. Magnusson, J. Guld, 1958, Bulletin of the World Health Organization.

The prevalence of bovine type tuberculous infection in man in the English rural population.

C. J. Stewart, I. Lesslie, K. Magnus, 1972, Tubercle.

MORBIDITY OF RESPIRATORY TUBERCULOSIS AMONG PERSONS INFECTED FROM BOVINE AND HUMAN SOURCES.

K. Magnus, 1964, Bulletin of the International Union against Tuberculosis.